UK markets closed
NIKKEI 225
38,460.08 +907.92 (+2.42%) HANG SENG
17,201.27 +372.34 (+2.21%) CRUDE OIL
82.84 +0.03 (+0.04%) GOLD FUTURES
2,328.90 -13.20 (-0.56%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,616.71 -1,622.69 (-3.05%)
Marinus Pharmaceuticals, Inc. (MRNS)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.4400 |
| Open | 1.4400 |
| Bid | 1.4300 x 2200 |
| Ask | 1.4600 x 5100 |
| Day's range | 1.3900 - 1.4600 |
| 52-week range | 1.1100 - 11.2600 |
| Volume | |
| Avg. volume | 1,721,345 |
| Market cap | 79.101M |
| Beta (5Y monthly) | 0.89 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Marinus (MRNS) Down 83% on Lead Drug Falling Short in Seizure Study
Interim results from a late-stage study show that Marinus' (MRNS) ganaxolone failed to meet the pre-specified stopping criteria in patients with refractory status epilepticus.
- Zacks
Do Options Traders Know Something About Marinus (MRNS) Stock We Don't?
Investors need to pay close attention to Marinus (MRNS) stock based on the movements in the options market lately.
- GuruFocus.com
Marinus Pharmaceuticals Inc (MRNS) Reports Full Year and Q4 2023 Financial Results
Key Financial Metrics Highlighted Amidst Clinical Advancements
© 2024 Yahoo. All rights reserved.